Literature DB >> 15704102

L1 augments cell migration and tumor growth but not beta3 integrin expression in ovarian carcinomas.

Daniela Gast1, Svenja Riedle, Svenja Riedle, Heidi Schabath, Sabine Schlich, Annette Schneider, Yasmin Issa, Alexander Stoeck, Mina Fogel, Safwan Joumaa, Till Wenger, Ingrid Herr, Paul Gutwein, Peter Altevogt.   

Abstract

L1 is a neural cell adhesion molecule involved in cell migration, axon growth and guidance. Recent data have shown that L1 is overexpressed in ovarian and endometrial tumors and is associated with bad prognosis. How L1 promotes tumor progression is presently unknown. Here we show that L1 expression is predominantly confined to the invasive front of ovarian carcinomas. Overexpression of L1 in carcinoma cell lines by adenovirus-mediated gene transfer enhanced the haptotactic cell migration on extracellular matrix proteins. Expression of L1 augmented tumor growth of carcinomas xenografted in nonobese diabetic/severe combined immunodeficient mice (NOD/SCID). A recent report has demonstrated L1-dependent upregulation of beta3 integrin involving activation of the extracellular signal-regulated kinase (erk) pathway. We find that L1 and beta3 integrin are not coexpressed in ovarian carcinoma tissues. Overexpression of L1 did not upregulate beta3 integrin in ovarian carcinoma cell lines but could do so in HEK293 cells. Our results suggest that L1 could drive progression by enhancing cell migration and tumor growth but that L1 dependent and erk-regulated gene expression requires cell-type specific elements. Copyright 2005 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15704102     DOI: 10.1002/ijc.20869

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  19 in total

1.  Role of L1 cell adhesion molecule (L1CAM) in the metastatic cascade: promotion of dissemination, colonization, and metastatic growth.

Authors:  Dirk Weinspach; Bastian Seubert; Susanne Schaten; Katja Honert; Susanne Sebens; Peter Altevogt; Achim Krüger
Journal:  Clin Exp Metastasis       Date:  2013-09-04       Impact factor: 5.150

2.  Characterization of patient-derived tumor xenografts (PDXs) as models for estrogen receptor positive (ER+HER2- and ER+HER2+) breast cancers.

Authors:  Noriko Kanaya; George Somlo; Jun Wu; Paul Frankel; Masaya Kai; Xueli Liu; Shang Victoria Wu; Duc Nguyen; Nymph Chan; Meng-Yin Hsieh; Michele Kirschenbaum; Laura Kruper; Courtney Vito; Behnam Badie; John H Yim; Yuan Yuan; Arti Hurria; Chu Peiguo; Joanne Mortimer; Shiuan Chen
Journal:  J Steroid Biochem Mol Biol       Date:  2016-05-03       Impact factor: 4.292

Review 3.  L1CAM malfunction in the nervous system and human carcinomas.

Authors:  Michael K E Schäfer; Peter Altevogt
Journal:  Cell Mol Life Sci       Date:  2010-03-17       Impact factor: 9.261

4.  L1CAM is an independent predictor of poor survival in endometrial cancer - An analysis of The Cancer Genome Atlas (TCGA).

Authors:  Thanh H Dellinger; David D Smith; Ching Ouyang; Charles D Warden; John C Williams; Ernest S Han
Journal:  Gynecol Oncol       Date:  2016-02-06       Impact factor: 5.482

5.  Acinar cell carcinomas of the pancreas: a molecular analysis in a series of 57 cases.

Authors:  Frank Bergmann; Sebastian Aulmann; Bence Sipos; Matthias Kloor; Anja von Heydebreck; Johannes Schweipert; Andreas Harjung; Philipp Mayer; Werner Hartwig; Gerhard Moldenhauer; David Capper; Gerhard Dyckhoff; Kolja Freier; Esther Herpel; Anja Schleider; Peter Schirmacher; Gunhild Mechtersheimer; Günter Klöppel; Hendrik Bläker
Journal:  Virchows Arch       Date:  2014-10-09       Impact factor: 4.064

6.  A role for exosomes in the constitutive and stimulus-induced ectodomain cleavage of L1 and CD44.

Authors:  Alexander Stoeck; Sascha Keller; Svenja Riedle; Michael P Sanderson; Steffen Runz; Francois Le Naour; Paul Gutwein; Andreas Ludwig; Eric Rubinstein; Peter Altevogt
Journal:  Biochem J       Date:  2006-02-01       Impact factor: 3.857

Review 7.  Adhesion molecule signalling: not always a sticky business.

Authors:  Ugo Cavallaro; Elisabetta Dejana
Journal:  Nat Rev Mol Cell Biol       Date:  2011-03       Impact factor: 94.444

8.  Enhanced L1CAM expression on pancreatic tumor endothelium mediates selective tumor cell transmigration.

Authors:  Yasmin Issa; Daniel Nummer; Tobias Seibel; Susanne Sebens Müerköster; Moritz Koch; Friedrich-Hubertus Schmitz-Winnenthal; Luis Galindo; Juergen Weitz; Philipp Beckhove; Peter Altevogt
Journal:  J Mol Med (Berl)       Date:  2008-10-18       Impact factor: 4.599

9.  A chimeric antibody to L1 cell adhesion molecule shows therapeutic effect in an intrahepatic cholangiocarcinoma model.

Authors:  Eung Suk Lee; Mun Sik Jeong; Rohit Singh; Juyeon Jung; Hyunho Yoon; Jeong Ki Min; Kyung Hyun Kim; Hyo Jeong Hong
Journal:  Exp Mol Med       Date:  2012-04-30       Impact factor: 8.718

10.  Full-length L1CAM and not its Δ2Δ27 splice variant promotes metastasis through induction of gelatinase expression.

Authors:  Stephanie Hauser; Laura Bickel; Dirk Weinspach; Michael Gerg; Michael K Schäfer; Marco Pfeifer; John Hazin; Florian Schelter; Ulrich H Weidle; Juliane Ramser; Juliane Volkmann; Alfons Meindl; Manfred Schmitt; Florian Schrötzlmair; Peter Altevogt; Achim Krüger
Journal:  PLoS One       Date:  2011-04-25       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.